SCNX
Scienture Holdings, Inc.
NASDAQ: SCNX · HEALTHCARE · PHARMACEUTICAL RETAILERS
$0.39
+5.08% today
Updated 2026-04-30
Market cap
$15.56M
P/E ratio
—
P/S ratio
36.05x
EPS (TTM)
$-2.70
Dividend yield
—
52W range
$0 – $3
Volume
3.6M
Scienture Holdings, Inc. (SCNX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $955881.00 | $1.50M | $2.91M | $2.48M | $2.93M | $3.83M | $7.44M | $17.12M | $9.89M | $10.25M | $1.36M | $136643.00 | $431609.00 |
| Revenue growth (YoY) | — | — | — | — | +56.5% | +94.7% | -14.8% | +18.1% | +30.7% | +94.1% | +130.3% | -42.2% | +3.6% | -86.7% | -90.0% | +215.9% |
| Cost of revenue | — | — | — | $944070.00 | $440047.00 | $189838.00 | $16362.00 | — | $449049.00 | $2.57M | $11.42M | $5.14M | $4.73M | $1.31M | $130638.00 | $100127.00 |
| Gross profit | — | — | — | $11811.00 | $1.06M | $2.72M | $2.47M | $2.93M | $3.38M | $4.87M | $5.71M | $4.75M | $5.52M | $49030.00 | $6005.00 | $-160299.00 |
| Gross margin | — | — | — | 1.2% | 70.6% | 93.5% | 99.3% | 100.0% | 88.3% | 65.5% | 33.3% | 48.0% | 53.8% | 3.6% | 4.4% | -37.1% |
| R&D | $3565.00 | — | — | — | — | — | — | $863324.00 | $949948.00 | — | $662726.00 | $899705.00 | $993185.00 | $0.00 | $2.24M | $1.96B |
| SG&A | $5160.00 | — | $28.50M | — | — | — | $3.34M | $1.41M | $3.47M | $4.38M | $7.49M | $7.54M | $6.57M | $4.35M | $12.05M | $10.33B |
| Operating income | $-8725.00 | $-28186.00 | $-28.50M | $-2.08M | $-1.43M | $-137070.00 | $-1.01M | $395095.00 | $-87616.00 | $125224.00 | $-2.51M | $-5.29M | $-2.92M | $-4.40M | $-14.70M | $-16.24M |
| Operating margin | — | — | — | -218.0% | -95.7% | -4.7% | -40.6% | 13.5% | -2.3% | 1.7% | -14.6% | -53.5% | -28.4% | -322.4% | -10758.7% | -3763.8% |
| EBITDA | $-8725.00 | $-28186.00 | $-28.50M | $-2.08M | $-2.00M | $-133268.00 | $-1.02M | $446039.00 | $66579.00 | $-136470.00 | $-2.40M | $-5.15M | $-1.87M | $-6.29M | $-17.39M | $-38.93M |
| EBITDA margin | — | — | — | -217.6% | -133.9% | -4.6% | -41.2% | 15.2% | 1.7% | -1.8% | -14.0% | -52.1% | -18.3% | -461.2% | -12726.5% | -9020.2% |
| EBIT | $-8725.00 | $-28186.00 | $-28.50M | $-2.08M | $-2.01M | $-137070.00 | $-1.01M | $395095.00 | $-87616.00 | $-231201.00 | $-2.51M | $-5.29M | $-2.07M | $-7.34M | $-17.44M | $-39.42M |
| Interest expense | — | — | — | $7281.00 | $4154.00 | $119512.00 | $151500.00 | $157056.00 | $57541.00 | $53227.00 | $29389.00 | $23590.00 | $336206.00 | $1.14M | $1.34M | $4.08M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-8725.00 | $-28186.00 | $-28.50M | $-2.09M | $-2.01M | $-1.12M | $-2.76M | $288983.00 | $9038.00 | $-284428.00 | $-2.54M | $-5.32M | $-3.47M | $-17.84M | $9.07M | $-41.51B |
| Net income growth (YoY) | — | -223.0% | -101003.4% | +92.7% | +3.8% | +44.5% | -147.1% | +110.5% | -96.9% | -3247.0% | -791.6% | -109.6% | +34.7% | -413.9% | +150.8% | -457999.7% |
| Profit margin | — | — | — | -218.8% | -134.5% | -38.4% | -111.2% | 9.9% | 0.2% | -3.8% | -14.8% | -53.8% | -33.9% | -1308.3% | 6634.7% | -9618025.6% |